Nick Vlassis’ Post

🤝 While the medical device industry, and orthopedics in particular, isn’t kind to mergers, Enovis’ roll-up—or as it prefers to say, its compounding value creator—strategy in ortho seems to be succeeding, due to disciplined M&A and execution of integration, and support for innovation. Its latest and largest test may be its deal to buy the regional player LimaCorporate for roughly €800 million. 💸 Management projects that the deal will establish Enovis squarely as a midsized player in an industry where four large competitors currently control 80% of the market. Chair and CEO Matt Trerotola says that Lima, which on its own is expected to have sales of roughly $300 million in 2024, will catapult Enovis into fifth place in ortho recon, a dramatic rise for a relatively new entrant that wasn’t a factor in the field until 2019. 🦶 Further, Enovis’ market strength varies by subsector from 2% share in hips and knees to roughly 10% in shoulder, with foot and ankle (F&A) in the middle-single digits, all subtleties that matter in a highly competitive industry, where scale and volume play large roles in success (see Figure 1). 📸 Source: Enovis: https://bit.ly/48y5yJn #medtech #medicaldevices #medtechinnovation #medtechinsights

🌟 Exciting News in Medical Device Manufacturing! 🌟 Acuity Surgical Devices has taken a significant step forward by investing in AddUp's FormUp 350 metal powder bed fusion system. This move marks a strategic shift towards vertical integration of manufacturing processes, enhancing control over cost, lead times, and quality. Founded in 2013, Acuity Surgical is known for its innovative spinal surgery solutions, including the Ventris ALIF Stand-Alone Anterior Lumbar System and others. By bringing the FormUp 350 in-house, Acuity aims to accelerate product development cycles and reduce reliance on external manufacturers. "The integration of FormUp 350 represents a pivotal moment for Acuity Surgical," said Bryan Cowan, CEO. "This partnership enhances our capabilities and underscores our commitment to delivering superior quality products." AddUp, known for its advanced manufacturing solutions, supports Acuity's transition with expertise from its ISO 13485 certified AddUp Solution Center, driving innovation in the medical device industry. Stay tuned as Acuity Surgical continues to innovate and elevate standards in healthcare! 🏥💡 #MedicalDevices #AdditiveManufacturing #InnovationInHealthcare #ManufacturingExcellence

Ophthalmic Equipment Market worth $88.5 billion by 2029 Download PDF Brochure:-https://lnkd.in/dW54FavV The global ophthalmic equipment market in terms of revenue was estimated to be worth $66.2 billion in 2023 and is poised to reach $88.5 billion by 2029, growing at a CAGR of 4.9% from 2023 to 2029. Global Ophthalmic Equipment Market Dynamics -Driver: Increase in eye disorders -Restraint: rising adoption of previously owned equipments -Opportunity: Low adoption of phacoemulsification devices and premium -IOLs in emerging regions -Challenge: Lack of skilled professionals 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bausch Health Companies Inc., Alcon Carl Zeiss Meditec Systems Johnson & Johnson Hoya THE COOPER COMPANIES GLOBAL HOLDINGS LP, EssilorLuxottica Canon Inc. Glaukos Corporation NIDEK USA. Topcon Corporation Ziemer Ophthalmic Systems STAAR Surgical Haag-Streit Lumibird Medical - Quantel Medical, Ellex & Optotek Coburn Technologies, Inc. FCI Ophthalmics Inc Matronix Optotechnik Private Limited HEINE Optotechnik Visionix Clear Labs BVI Medical Corza Medical Appasamy Associates Ophtec Lumenis #ophthalmology #ophthalmicequipment #eyecare #visionhealth #medicaldevices

Ophthalmic Equipment Market worth $88.5 billion by 2029 Download PDF Brochure:-https://lnkd.in/dPXUjBGv The global ophthalmic equipment market in terms of revenue was estimated to be worth $66.2 billion in 2023 and is poised to reach $88.5 billion by 2029, growing at a CAGR of 4.9% from 2023 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bausch Health Companies Inc. Alcon ZEISS Medical Technology Johnson & Johnson Hoya THE COOPER COMPANIES GLOBAL HOLDINGS LP, EssilorLuxottica Canon Inc. Glaukos Corporation NIDEK USA Topcon Corporation Ziemer Ophthalmic Systems STAAR Surgical Haag-Streit Lumibird Medical - Quantel Medical, Ellex & Optotek Coburn Technologies, Inc. FCI Ophthalmics Inc Matronix Optotechnik Private Limited HEINE Optotechnik Visionix Neo Vision Clear Labs BVI Medical Corza Medical Appasamy Associates Ophtec Lumenis Intuvision #ophthalmology #eyecare #visioncare #optometry #ophthalmicdevices

Ophthalmic Equipment Market worth $88.5 billion by 2029 Download PDF Brochure:-https://lnkd.in/dMq4Hazs The global ophthalmic equipment market in terms of revenue was estimated to be worth $66.2 billion in 2023 and is poised to reach $88.5 billion by 2029, growing at a CAGR of 4.9% from 2023 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bausch Health Companies Inc. Alcon Carl Zeiss Meditec Systems Johnson & Johnson Hoya Vision Care EssilorLuxottica Canon Inc. Glaukos Corporation NIDEK USA., Topcon Corporation Ziemer Ophthalmic Systems STAAR Surgical Haag-Streit QUANTEL MEDICAL Coburn Technologies, Inc. FCI Ophthalmics Inc Matronix Optotechnik Private Limited HEINE Optotechnik Visionix Neo Vision Clear Labs BVI Medical Corza Medical Appasamy Associates Ophtec Lumenis Intuvision #ophthalmology #eyecare #ophthalmicequipment #visioncare #eyehealth

As companies navigate leadership changes, legal challenges, and financial growth, their strategies will undoubtedly shape the future of healthcare innovation. It's crucial to consider the significant advancements in the spine and orthopaedic medtech industries. Here's a quick recap: 1. restor3d Strengthens Leadership: restor3d hired two new senior leaders, Larry Hazbun as Senior VP of Robotics and Kirstin Widding as Senior VP of Hip and Knee. Both bring extensive industry experience, bolstering the company's expertise. 2. Orthofix Appoints a New President: Orthofix has named Patrick Fisher as President of its global orthopaedics business. Fisher brings a strong background from Stryker and Wright Medical to lead the company's orthopaedic division. 3. Legal Scrutiny for Globus Medical: Globus Medical is under investigation following an FDA warning about its Excelsius GPS spine robot. The warning led to a 7% drop in the company’s stock. Multiple law firms are probing potential violations, while Globus works to address the FDA's concerns. 4. Medtronic's Strong Q1 Performance: Medtronic reported $7.9 billion in Q1 sales, a 2.8% increase year over year. The cranial and spinal technologies segment grew 4%, contributing to a strong overall performance and a 32% rise in net income. These developments underscore the dynamic nature of the spine and orthopaedic medtech industries. Stay tuned and follow TRESP Recruitment - Medtech and Healthtech Experts for more updates as the industry continues to evolve. https://lnkd.in/gvZcJ-YM #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #HealthcareTechnology #MedDeviceNews #HealthcareNews #MedTechTrends

In this edition of Leadership Link, I sat down with Sharrolyn Transfeldt Josse, WW President of Joint Reconstruction at Johnson & Johnson MedTech | Orthopaedics. Over the past few years, our momentum has been unstoppable - launching new and highly differentiated products including our full procedure approach of implants, advanced surgical techniques and enabling tech. Hear more on how we are improving patient outcomes in joint reconstruction below. #mycompany

Orthopedics Trend #17: A Shift to Long-Term Thinking Largely due to the new financial environment, startups are focusing on building substantial, enduring businesses, and avoiding the pitfalls of premature exits. A second order effect of long-term thinking is that CEOs are strategizing for financial sustainability, aiming for cash flow positivity or breakeven in a growth-aligned manner. Explore 21 more trends redefining the orthopedics landscape here - https://lnkd.in/efNSUCTi

Listen to Kevin Bly's 60-second Elevator Pitch! Kevin does a tremendous job describing his company, New Age Medical! This video is part of our Healthcare HotShot series! Meet Kevin Bly, Founder and CEO of New Age Medical. He succinctly describes their truly innovative approach to working with hospitals, surgeons, and manufacturers of PPI items. ✅𝐔𝐧𝐢𝐪𝐮𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐨𝐝𝐞𝐥: New Age Medical operates distinctively as a transactional entity directly with hospitals, surgery centers, or healthcare systems, distinguishing itself from typical distributors in the market. This setup allows them to directly manage the sales and distribution process, ensuring a more streamlined and responsive interaction with healthcare providers. ✅𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐢𝐯𝐞𝐫𝐬𝐞 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬: The company aggregates a portfolio from many small and mid-sized manufacturers, offering a dynamic range of spinal implants and orthobiologics. This strategy broadens the selection available to healthcare providers but also enables the company to tailor solutions to meet its client's specific needs and challenges. Excellent work, Kevin! An impressive service and solution. If you are a CEO/Founder, reach out if you are interested in being highlighted! The Institute of Healthcare Executives and Suppliers, (IHES) Council of Supply Chain Executives Council of Pharmacy Executives and Suppliers (CPES) #hchotshots #supplychain #medicaldevice

Medline UNITE Foot & Ankle partnered with ImplantBase—a single, comprehensive solution that provides a complete, real-time picture of your moving inventory and associated financials. Designed specifically for orthopedic/spine medical device companies, ImplantBase’s all-in-one cloud platform unifies your operations to enhance productivity, unlock capital, and encourage innovation. If better financial KPIs—or significant growth goals—are on your agenda, click the link to see how Medline Unite achieved 800% growth. https://hubs.ly/Q02GcgDP0